Trial Profile

Open-label randomised controlled trial of tolvaptan versus fluid restriction in acutely hospitalised patients with euvolaemic or hypervolaemic hyponatraemia

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 11 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tolvaptan (Primary)
Indications Hyponatraemia
Focus Therapeutic Use
Acronyms TVFR-HypoNa

Most Recent Events

12 Apr 2022 Trial design published in the Trials
15 Jun 2021 Planned initiation date changed from 1 Feb 2020 to 21 May 2021.
15 Jun 2021 Planned End Date changed from 5 Jul 2020 to 4 Feb 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com